Scientific Director, Pharmacogenomics And Clinical Trials
CurrentDoing clinical trials as Principal Investigator for FDA registration Trials and Investigator initiated studies. Trials are with the notion of response prediction in medications which interact with the Reward circuitry and the Dopamine system.Principal InvestigatorAn outpatient double blind placebo control dose ranging study of efficacy of Aripiprazole (BMS) in stabilization, maintenance and relapse prevention of Bipolar Mania, 1999- 2002.An outpatient double blind placebo control dose ranging study of safety, tolerability and efficacy of Paroxetine ( GSK) in treatment of adolescents with major depression, 1999- 2001.An in-patient double blind, placebo control study of safety, tolerability and efficacy of Ziprasidone (Pfizer) in treatment of acute Bipolar Mania, 1999- 2000.